Michael Braun
About Michael Braun
Michael Braun is the Senior Vice President of Immunology and Fibrosis at Bristol Myers Squibb, with extensive experience in various therapeutic areas from his previous roles at Novartis and Pharmacia.
Title and Current Position
Michael Braun holds the title of Senior Vice President, Immunology and Fibrosis at Bristol Myers Squibb. He is based in Princeton, New Jersey, United States, where he has been working since June 2022. In this role, Michael focuses on advancing the field of immunology and fibrosis through innovative research and development.
Previous Roles at Novartis
Before joining Bristol Myers Squibb, Michael Braun had an extensive career at Novartis, spanning over 13 years. His roles included Vice President & Head, Immunology, Hepatology & Dermatology from 2019 to 2022, and World Wide Head Migraine & Alzheimer's Disease from 2017 to 2019 in the Basel Area, Switzerland. He has also served as Head of Marketing, Rheumatology and worked on New Products Commercialization for Immunology & Respiratory in the Greater New York City Area. Michael's tenure at Novartis began with a role as a Sales Representative and progressed through numerous leadership positions.
Career Beginnings
Michael Braun started his professional journey at ZS Associates as a Business Associate from 1999 to 2001 in the Greater Chicago Area. He then moved to Pharmacia, where he worked as Senior Manager, Targeting and Alignments for two years before transitioning to Novartis. At Novartis, he initially took on the role of Senior Manager, Neuroscience Operations, coinciding with various other developmental positions until becoming Director, Provider Segment Marketing.
Expertise in Therapeutic Areas
Michael Braun has extensive experience and expertise in various therapeutic areas including immunology, hepatology, dermatology, migraine, Alzheimer's disease, rheumatology, respiratory, and psychiatry marketing. His broad range of skills were developed through his work in different high-level positions at Novartis and now at Bristol Myers Squibb, where he continues to drive scientific innovation.
Leadership and Impact in Biopharmaceutical Research
Throughout his career, Michael Braun has demonstrated a commitment to scientific excellence and innovation in biopharmaceutical research. In his role at Bristol Myers Squibb, he is involved in the development of transformational medicines that address autoimmune diseases and fibrotic conditions. His leadership aims at fostering a collaborative environment to advance the understanding and treatment of complex medical conditions.